Neoadjuvant Toripalimab Combined With Chemotherapy in the Treatment of Malignant Pleural Mesothelioma
Status:
Not yet recruiting
Trial end date:
2025-05-31
Target enrollment:
Participant gender:
Summary
This is a single-arm, open, II phase study to evaluate the safety and efficacy of
Toripalimab, pemetrexed and carboplatin in the treatment of locally advanced malignant MPM in
15 newly diagnosed patients with locally advanced malignant MPM.